Glucox Biotech – The Next Generation Diabetes Drugs<meta name="description" content="The primary goal of Glucox Biotech is to develop a clinically applicable therapeutic drug for treatment of type 2 diabetes and insulin resistance." /> <meta name="keywords" content="glucox, diabetes, insulin, treatment, type 2, drug, glx, biotech, genetic, screening" />

Projects in Pipeline

Portfolio Overview

Glucox Biotech project portfolio comprises two potential and innovative project. The main is the diabetes project built on Glucox Biotech exclusive patent proprietary.

Diabetes drug

Molecule	Medical condition	Status
GLX 010	insulin resistance	pre-clinical
GLX 118	insulin resistance	discovery
GLX 007	insulin resistance	discovery

Genetic Screening

The second project is genetic screening for identification of disease pathways for optimal drug target selection. The identification of novel therapeutic targets leads to better and potentially definite treatment of various diseases and identification of diagnostic and risk factors for the chosen diseases.